Kilsyth, United Kingdom

Ronald Palin

This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald Palin. Retrieved from https://idiyas.com/inventor/ronald-palin-o6gvr0tu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ronald Palin: Innovator in Neuromuscular Block Reversal

Introduction

Ronald Palin is a notable inventor based near Kilsyth, GB. He has made significant contributions to the field of pharmacology, particularly in the development of reversal agents for drug-induced neuromuscular block.

Latest Patents

Palin holds a patent for "6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block." This patent discloses a 6-mercapto-cyclodextrin derivative characterized by a general formula that includes various alkylene and phenylene groups. The compound is designed to be highly suitable for reversing drug-induced neuromuscular block, showcasing its potential in medical applications.

Career Highlights

Ronald Palin is associated with Akzo Nobel N.V., where he continues to work on innovative solutions in the pharmaceutical sector. His expertise in the field has led to advancements that could improve patient outcomes in surgeries and other medical procedures requiring neuromuscular blockade.

Collaborations

Palin has collaborated with notable colleagues, including Mingqiang Zhang and David Jonathan Bennett. These partnerships have likely contributed to the development and refinement of his patented technologies.

Conclusion

Ronald Palin's work in developing 6-mercapto-cyclodextrin derivatives represents a significant advancement in the field of pharmacology. His contributions are poised to enhance the effectiveness of neuromuscular block reversal, benefiting both medical professionals and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…